Citation: (b)(6) et al.Early outcomes for valve-in-valve tavr in degenerative freestyle bioprostheses.Seminars in thoracic and cardiovascular surgery (2017) doi 10.1053/j.Semtcvs.2017.11.001 earliest date of e-publish/publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information, it cannot be determined whether this event has been previously reported.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature review regarding the outcomes after the implant of a valve-in-valve transcatheter aortic valve (tavr) into a freestyle stentless bioprosthesis.All data were collected from a single center between 2014 and 2016.The study population included 22 patients, who were implanted with a corevalve or an evolut r transcatheter bioprosthetic aortic valve.Serial numbers were not provided.The study population was predominantly male; mean age 74 + 9 years.Among all patients previously implanted with a freestyle, adverse events included: severe regurgitation due to flail leaflet or malcoaptation leaflet, severe stenosis, and calcification.No additional adverse patient effects or product performance issues were reported.
|